4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. Leveraging its proprietary XV Technology and Imbio Technology, the Company provides cutting-edge thoracic imaging that enhances physician diagnoses and management of respiratory conditions. XV technology delivers detailed insights to airflow, lung structure, and regional lung function through a patient’s complete breath cycle. The company produces software and hardware products that enable new levels of non-invasive, quantitative analysis of lung function. Its products include CAC (Coronary Artery Calcification), CT-LVAS (Computed Tomography Lung Ventilation Analysis Software), IQ-UIP, LDAf (Functional Lung Density Analysis), LDAi (Lung Density Analysis-Inspiration), LTA (Lung Texture Analysis), PHA Analysis (Pulmonary Hypertension Assessment), XV LVAS (X-ray Velocimetry Lung Ventilation Analysis Software), and XV Scanner.
Quelle est la performance du prix de l'action 4DMEDICAL LTD ?
Le prix actuel de 4DMEDICAL LTD est de $3.16, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de 4DMedical Limited ?
4DMedical Limited appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de 4DMedical Limited ?
La capitalisation boursière actuelle de 4DMedical Limited est de $1.8B
Est-ce que 4DMedical Limited est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 6 analystes ont établi des notations d'analystes pour 4DMedical Limited, y compris 2 achat fort, 3 achat, 1 maintien, 0 vente et 2 vente forte